Ignyta Lands $6,000,000 Series B Financing

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    11575 Sorrento Valley Road San Diego, CA 92121
  • Company Description
    Ignyta, Inc. is a scientifically driven biotechnology company catalyzing personalized medicine in autoimmune diseases. Our goals are to revolutionize the quality of biomarkers and tests available to rheumatologists and patients to help them make better informed, more individualized treatment decisions; and to identify truly novel autoimmune disease targets for biopharmaceutical companies to enable the development of precise therapies for patients worldwide.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series B
  • Proceeds Purposes
    The company plans to use proceeds of its current round in 2013 to begin clinical studies to confirm its molecular based assay for diagnosing RA at its earliest, most-treatable stages.
  • M&A Terms
  • Venture Investor
    City Hill Ventures
  • Venture Investor
    Colt Ventures
  • Venture Investor

Trending on Xconomy